Disruption of differentiation in human cancer: AML shows the way
The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
Abstract
Although much is understood about the ways in which transcription factors regulate various differentiation systems, and one of the hallmarks of many human cancers is a lack of cellular differentiation, relatively few reports have linked these two processes. Recent studies of acute myeloid leukaemia (AML), however, have indicated how disruption of transcription-factor function can disrupt normal cellular differentiation and lead to cancer. This model involves lineage-specific transcription factors, which are involved in normal haematopoietic differentiation. These factors are often targeted in AML--either by direct mutation or by interference from translocation proteins. Uncovering these underlying pathways will improve the diagnosis and treatment of AML, and provide a working model for other types of human cancer, including solid tumours.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Autoregulation may be a common feature of several transcriptional regulators to augment the relatively irreversible nature of differentiation processes in the hematopoietic system (60,61).”
From Potential Autoregulation of Transcription Factor PU.1 by an Upstream Regulatory Element (2005) · cites this paper as [60]
Citations
Cites
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
Bonnet, D., & Dick, J. E. (1997) · Nature Medicine · doi:10.1038/nm0797-730 · Cited by 5,864 · cited 1×
“What is the role of lineage-specific transcription factors on stem cells, and how does this relate to AML? Although most of the blast cells from patients with AML clearly show a lineage- and stage-specific differentiation block, several studies support the idea that it is a disease that also involves the stem-cell com…”
BackgroundBennett, J. M., Catovsky, D., Daniel, M., Flandrin, G., Galton, D. A. G., Gralnick, H. R., & Sultan, C. (1976) · British Journal of Haematology · doi:10.1111/j.1365-2141.1976.tb03563.x · Cited by 5,602
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
Purification and Characterization of Mouse Hematopoietic Stem Cells
Spangrude, G. J., Heimfeld, S., & Weissman, I. L. (1988) · Science · doi:10.1126/science.2898810 · Cited by 2,824
Grimwade, D., Walker, H., Oliver, F., Wheatley, K., Harrison, C., Harrison, G., Rees, J., Hann, I., Stevens, R., Burnett, A., et al. (1998) · Blood · doi:10.1182/blood.v92.7.2322 · Cited by 2,655
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
Akashi, K., Traver, D., Miyamoto, T., & Weissman, I. L. (2000) · Nature · doi:10.1038/35004599 · Cited by 2,617
In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse
Schwarze, S. R., Ho, A., Vocero-Akbani, A., & Dowdy, S. F. (1999) · Science · doi:10.1126/science.285.5433.1569 · Cited by 2,416
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras
Jackson, E. L., Willis, N., Mercer, K., Bronson, R. T., Crowley, D., Montoya, R., Jacks, T., & Tuveson, D. A. (2001) · Genes & Development · doi:10.1101/gad.943001 · Cited by 1,898 · cited 1×
“This could be applied either in treating bone marrow ex vivo with differentiation agents, followed by bone-marrow transplantation for re-introduction into the patient, or by local therapies, such as instillation into the lung by bronchoscop”
MethodOkuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G., & Downing, J. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80986-1 · Cited by 1,856 · cited 1×
“Whereas AML1 falls into the category of transcription factors that are involved in the development of haematopoietic cells from haemangioblasts (SCL is another), and disruption of AML1 results in loss of all definitive haematopoiesi”
Background
Research works printed but not linked: 2
- Zhang, P. et al. C/EBPα deficiency blocks granulocytic differentiation at the common myeloid progenitor stage in both adult and fetal liver myelopoiesis. Blood 98, 792a (2001).
- Duprez, E. A., Koch, H. & Tenen, D. G. C/EBPβ is an important target of PML–RARA during ATRA induced differentiation of APL cells. Blood 98, 833a (2001).
Cited by
Items 501–600 of 620
The Occurrence of Malignancy in Trypanosoma brucei brucei by Rapid Passage in Mice
Cai, X.-L., Li, S.-J., Zhang, P., Li, Z., Hide, G., Lai, D., & Lun, Z. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.806626 · Cited by 4
“…of biological and genomic characteristics of these parasitic protozoa and a comparison with characteristics of malignant tumor cells (Sachs, 1986; Tenen, 2003; Murgia et al., 2006; Rebbeck et al., 2009; Hanahan and Weinberg, 2011; Carnes et al., 2015), it has been suggested that T. evansi and T.…”
BackgroundDecreased PU.1 expression in mature B cells induces lymphomagenesis
Endo, S., Nishimura, N., Toyoda, K., Komohara, Y., Carreras, J., Yuki, H., Shichijo, T., Ueno, S., Ueno, N., Hirata, S., et al. (2024) · Cancer Science · doi:10.1111/cas.16344 · Cited by 4
Self-citationES02.01 Transcriptional regulation of haematopoiesis
Göttgens, B. (2004) · Vox Sanguinis · doi:10.1111/j.1741-6892.2004.00423.x · Cited by 3
Molecular Biology and Cytogenetics of Chronic Myeloid Leukemia
Quintás‐Cardama, A., Kantarjian, H. M., & Cortes, J. E. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3764-2_4 · Cited by 4
Zhou, F., Jin, R., Hu, Y., & Mei, H. (2017) · Molecular Cytogenetics · doi:10.1186/s13039-017-0322-8 · Cited by 3
“CCAAT enhancer binding protein α (C/EBPα), a general inhibitor of cell proliferation and a tumor suppressor [31] plays a pivotal role in early granulocyte development.”
BackgroundNecdin modulates leukemia-initiating cell quiescence and chemotherapy response
Yao, C., Kobayashi, M., Chen, S., Nabinger, S. C., Gao, R., Liu, S. Z., Asai, T., & Liu, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.20999 · Cited by 3
Molecular Biology and Cytogenetics of Chronic Myeloid Leukemia
Konopleva, M. Y., Quintás‐Cardama, A., Kantarjian, H. M., & Cortes, J. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-64263-5_4 · Cited by 3
CMV seropositivity and mycosis fungoides—the Indian perspectives
Ghosh, K. (2003) · Blood · doi:10.1182/blood-2003-05-1563 · Cited by 3
Aryal, S., Curtiss, B. M., Zhou, X., Lu, R., & Cheng, C. (2026) · Leukemia · doi:10.1038/s41375-026-02917-2 · Cited by 3
Whole genome, exon mutation and transcriptomic profiling of acute myeloid leukemia: A case report
Lai, S., Li, Y., Zhang, S., Deng, R., Deng, Y., & Fan, F. (2021) · Oncology Letters · doi:10.3892/ol.2021.12820 · Cited by 2
“Due to chromosomal abnormalities and genetic mutations, the normal hematopoi‐ etic system undergoes malignant transformation at different stages, which causes blockade of blood cell differentiation and results in different subtypes of AML in the process of directional myeloid differentiation (2).”
BackgroundHe, Y. J., Li, X. J., Wang, D., Zhang, E., Hu, Y., Wang, W., Huang, R., & Xiao, R. (2014) · Journal of International Medical Research · doi:10.1177/0300060514540630 · Cited by 3
Menshawy, N. E., Shahin, D. A., & Ghazi, H. F. (2014) · Turkish Journal of Hematology · doi:10.4274/tjh.2012.0063 · Cited by 2
“However, expression of transcription factors and their implications in various human leukemia types are not well understood [1].”
De Novo Acute Myeloid Leukemia in Adults
Akhter, A., Patel, J. L., Farooq, F., Qureshi, A., Taher-Rad, M.-S., Elyamany, G., Al-Zahrani, A. M., Rashid-Kolvear, F., & Mansoor, A. (2015) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000145 · Cited by 2
Exploiting a key transcriptional dependency: ZMYND8 and IRF8 in AML
Taylor, S. J., Sundaravel, S., & Steidl, U. G. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.08.013 · Cited by 2
Grimwade, D. J. (2008) · Springer eBooks · doi:10.1007/978-0-387-87366-4_16 · Cited by 2
Therapy-related acute lymphoblastic leukemia with t(8;14)(q11;32) but not 11q23 abnormality
Chen, W., & Huang, Q. M. (2009) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190802652000 · Cited by 2
“CEBPD gene, was identified in chromosome 8q11, codes for a member of CCAAT enhancer-binding proteins family, which is defined by conserved carboxy-terminal domains consisting of a leucine zipper dimerisation and basic DNA-binding domains, plays pivotal roles in the proliferation and differentiation [6,12].”
BackgroundSingle-Cell Atlas of AML Reveals Age-Related Gene Regulatory Networks in t(8;21) AMLPreprint
Whittle, J., Meyer, S., Lacaud, G., Baker, S. M., & Iqbal, M. (2025) · eLife · doi:10.7554/elife.104978.1 · Cited by 2
The Role of NOL7 in All-Trans Retinoic Acid-Induced Acute Promyelocytic Leukemia Cells
Ekmekçi, S. S. (2020) · International Journal of Hematology and Oncology · doi:10.4999/uhod.204139 · Cited by 1
RNA activation of CEBPA improves leukemia treatment
Kovecses, O., Sharif-Askari, B., González‐Losada, C., Reebye, V., Ryan, B. M., Kwok, A., Habib, N., Luedtke, N. W., Mercier, F., & McKeague, M. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102611 · Cited by 3
“8,9 Under physiological conditions, C/EBP α activity limits myeloid progenitor proliferation 10,11 by inducing cell-cycle exit 12–14 through modulation of cell-cycle-related factors (transcription of p21, 10 repression of E2F, 13 and suppression of c-Myc 15 ) and promotes terminal myeloid…”
Visomitin as a differentiation-inducing therapeutic agent through SYK inhibition in AML
Jeon, B.-E., Kwon, C.-S., Lee, J.-E., Lee, S.-J., Cho, Y., Shin, H., Kim, S., & Jung, Y. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1741351 · Cited by 1
“Acute myeloid leukemia (AML) is a malignant tumor characterized by arrested differentiation of hematopoietic progenitor cells and abnormal proliferation of cancer cells (Tenen, 2003; Nowak et al., 2009).”
Targeting ZMIZ1 induces differentiation in acute myeloid leukemia via chromatin remodeling
Li, H., Liu, Y., Cui, J., Fu, Z., Xu, Y., Yang, S., Zhu, K., Xue, Y., Zhang, Y., Zhao, Y., et al. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02766-6 · Cited by 1
“5 A de fi ning pathogenic feature of AML is the blockade of myeloid differentiation, 6 resulting in the accumulation of immature blasts and impaired hematopoiesis.”
Lineage-Specific Transcription Factor Aberrations in AML
Mueller, B. U., & Pabst, T. (2009) · Cancer treatment and research · doi:10.1007/978-0-387-69259-3_7 · Cited by 3
Development of genomic markers that predict response to molecularly targeted antileukemic therapy
Raponi, M., & Harousseau, J. (2008) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2.4.361 · Cited by 1
El-Sharnouby, J. A., Ahmed, L. M. S., Taha, A. A., & Okasha, K. M. (2010) · Electronic Journal of General Medicine · doi:10.29333/ejgm/82788 · Cited by 1
“Platelet count, ×109/L Range (10-190) (20-310) 0.”
BackgroundZada, P., & Ali, A. M. (2004) · Cited by 1
Wolff, L., Ackerman, S. J., & Nucifora, G. (2005) · Experimental Hematology · doi:10.1016/j.exphem.2005.09.011 · Cited by 1
High expression of FCHSD2 is associated with chemoresistance in adult acute myeloid leukemia
Eldahshan, D. H., Metwaly, H., Sheir, R. E.-S., & Aly, T. (2013) · Comparative Clinical Pathology · doi:10.1007/s00580-013-1802-9 · Cited by 1
“Induction chemotherapy, consisting of a combination of an anthracycline such as daunorubicin or idarubicin and a nucleoside analog such as cytarabine, can result in complete remissions inmany patients (Tenen 2003).”
BackgroundRisikoadaptierte Therapie der akuten myeloischen Leukämie
Fiegl, M., & Hiddemann, W. (2012) · Der Internist · doi:10.1007/s00108-011-2986-1 · Cited by 3
“Es gilt als gesichert, dass dieser Transfor mation mindestens 2 molekulare Aber rationen zugrunde liegen, die gemeinsam zu einer Beeinträchtigung der Differen zierung und Proliferation führen [19, 20].”
BackgroundThe genetics of chronic myelogenous leukaemia
May, P. C., Khorashad, J. S., Alikian, M., Perrotti, D., & Reid, A. G. (2016) · Wiley eBooks · doi:10.1002/9781118527948.ch7 · Cited by 1
MicroRNAs and Cancer Connecting the Dots
Jayasena, S. D. (2009) · CRC Press eBooks · doi:10.1201/9781420008708.ch19 · Cited by 1
The Role of Hematopoietic Progenitor Cells in Retroviral Pathogenesis
Banerjee, P., Samuelson, E., & Feuer, G. (2010) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814295314_0001 · Cited by 1
Zhang, C., Song, G., Song, G., Li, R., Gao, M., & Zhang, H. (2017) · PubMed · Cited by 1
Lan, Y., Li, M., & Mi, S. (2021) · Genes · doi:10.3390/genes12050630 · Cited by 1
“Under this model of hematopoietic development, blockage in the myeloid differentiation at different stage could result in an accumulation of different immature myeloid cells in the bone marrow and peripheral blood, which is usually manifested by myeloid leukemia, leading to the concept that differentiation arrest is a…”
BackgroundThe miR-146b-3p/TNFAIP2 axis regulates cell differentiation in acute myeloid leukaemia
Lan, G., Wu, X., Zhao, A., Lan, J., Guo, Q., Wang, B., Shen, F., Yu, X., Zhao, Y., Gao, R., et al. (2024) · Aging · doi:10.18632/aging.205441 · Cited by 1
Advances in New Targets for Differentiation Therapy of Acute Myeloid Leukemia
Yao, J., Zhao, M., Wang, J., & Wei, L. (2020) · Journal of cancer research updates · doi:10.30683/1929-2279.2020.09.10 · Cited by 1
ABERRANT EPIGENETICS IN THE MOLECULAR PATHOGENESIS OF HUMAN ACUTE MYELOID LEUKEMIA
Scott, S. A. (2005) · University Library - University of Saskatchewan (University of Saskatchewan) · Cited by 1
The role of miRNA in hematopoiesis
Scherr, M., & Eder, M. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511541766.037 · Cited by 1
Mesquita, D. R. (2009) · Americanae (AECID Library) · Cited by 1
Precision Treatment of Acute Myeloid Leukemia : Predictive Response Biomarkers for BET inhibitor JQ1
Saad, J. J. (2018) · UTUPub (University of Turku) · Cited by 1
High Resolution Comparison of Cancer-Related Developmental Processes Using Trajectory AlignmentPreprint
Alpert, A., Starosvetsky, E., Hayun, M., Ofran, Y., & Shen-Orr, S. S. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/469601 · Cited by 1
“While these principles apply to numerous cancers, they are highly relevant in acute myeloid leukemia (AML), the most common acute leukemia in adulthood 2 , in which myeloid progenitor cells spanning various developmental stages (blasts) are accumulated in the bone marrow 1 .”
BackgroundSingle-Cell Atlas of AML Reveals Age-Related Gene Regulatory Networks in t(8;21) AMLPreprint
Whittle, J., Meyer, S., Lacaud, G., Baker, S. M., & Iqbal, M. (2025) · eLife · doi:10.7554/elife.104978.2 · Cited by 1
Combinatorial inhibition of LSD1 and Menin induces therapeutic differentiation in AMLPreprint
Rodríguez, M. F. C., Rico, J., Vijayaraghavan, M., Yan, F., King, A., Petroni, R., Leu, N. A., Goodrow, H., Bernt, K. M., McGeehan, G. M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.09.687496 · Cited by 1
Cetinkaya, C. (2005) · Epsilon Open Archive (Sveriges lantbruksuniversitet biblioteket (Swedish University of Agricultural Sciences))
The Role of Schwann Cell Mitochondrial Metabolism in Schwann Cell Biology and Axonal Survival
Viader, A. (2011) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7319sxj
Translational Control in Myeloid Disease
Abayasekara, N., & Khanna‐Gupta, A. (2012) · InTech eBooks · doi:10.5772/34891
“C/EBP is a master regulator of granulopoiesis (Tenen, 2003).”
BackgroundInfluentialChau, B. N., Bergseid, J., & Wang, J. Y. J. (2006) · Wiley eBooks · doi:10.1002/9783527619665.ch21
The epigenetic regulation of RIZ1 in human leukemia
Beaton-Brown, E. L. D. (2008) · University Library - University of Saskatchewan (University of Saskatchewan)
Friedenson, B. (2009) · Humana Press eBooks · doi:10.1007/978-1-60761-178-3_10
“This would cooperate with other mechanisms that create a differentiation block [80, 81].”
BackgroundCharacterization of the putative CALM/AF10 collaborator Meis1 in leukemia development
Sen, D. (2013) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.16070
The Role of the Forkhead Transcription Factor Foxo3a in Erythropoiesis
Bakker, W. J. (2005)
Genomic and Epigenomic Studies of Acute Myeloid Leukemia with CEBPA Abnormalities
Wouters, B. J. (2009) · EUR Research Repository (Erasmus University Rotterdam)
Studies on Genetic Aberrations in Acute Myeloid Leukemia
Abbas, S. (2011) · EUR Research Repository (Erasmus University Rotterdam)
Targeting Leukemia Stem Cells and Stem Cell Pathways in ALL
Pridans, C., & Huntly, B. J. P. (2011) · Springer eBooks · doi:10.1007/978-1-4419-8459-3_8
Characterization of the Proteins HPIP and VENTX2 as Novel Regulatory Proteins of Human Hematopoiesis
Arseni, N. (2006) · Site cant be reached · doi:10.5282/edoc.5672
Functions of the retinoblastoma protein that contribute to tumor suppression
Ewen, M. E. (2005) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2005.05.031
Biologie und risikoadaptierte Therapie der akuten myeloischen Leukämie
Krämer, A. (2009) · Onkopipeline · doi:10.1007/s15035-009-0152-1
LEUKEMIA STEM CELLS: STUDYING THE ROOT OF LEUKEMIA
PEARCE, D. J., & Bonnet, D. A. (2006) · Gene Therapy and Regulation · doi:10.1142/s1568558607000058
“This concept is supported by the correlation between genes required for normal hematopoietic development and those perturbed in leukemia (Tenen, 2003), and by the recent demonstration that Bmi-1 plays a key role in self-renewal determination in both normal and leukemic murine stem cells (Lessard and Sauvageau, 2003; P…”
BackgroundLiebermann, D. A., & Hoffman‐Liebermann, B. (2006) · Nature Methods · doi:10.1038/nmeth0406-248
Abelev, G. I. (2006) · Russian Journal of Developmental Biology · doi:10.1134/s1062360406030076
“The mechanisms of transformation in tumors of the hemopoietic tissues are intimately related to the mechanisms of its differentiation (Abelev, 2000; Tenen, 2003).”
BackgroundInfluentialDeciphering the Pathogenesis of Acute Myeloid Leukemia
Reckzeh, K. (2012) · Lund University Publications (Lund University)
Pieters, K. (2005) · Lund University Publications (Lund University)
The RUNX1 Transcription Factor: A Gatekeeper in Acute Leukemia
Stocking, C., Niebuhr, B., Fischer, M., Täger, M., & Cammenga, J. (2007) · NATO science for peace and security series. A, Chemistry and biology · doi:10.1007/978-1-4020-6469-2_14
Zada, A. A. P., & Al-Qahtani, M. H. (2011) · Saudi Medical Journal · doi:10.15537/1658-3175.5246 · Cited by 2
A case of acute erythroleukemia with concurrence of BCR–ABL and FLT3-TKD (D835E) mutation
Cheng, W., Yang, X., Ping, N., Chen, S., & Sun, A. (2014) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2014.999330
Genome-Scale Technology Driven Advances to Research into Normal and Malignant Haematopoiesis
Göttgens, B. (2012) · Scientifica · doi:10.6064/2012/437956
“e various types of human leukaemias all share the property of perturbed blood cell production, oen with an accumulation of the so-called blast cells that resemble immature blood progenitor cells [7].”
BackgroundPulikkan, J. A. (2008) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.10298
Bingham, E. J. (2010) · University Library - University of Saskatchewan (University of Saskatchewan)
THE BIOLOGICAL FUNCTION OF INTERACTING PARTNERS OF ZXD FAMILY PROTEINS
Koneni, R. (2009) · EngagedScholarship @ Cleveland State University (Cleveland State University)
Screening for RAG activity in haematopoietic tumours using a novel reporter strategy
Trancoso, I. (2009) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
The role of the tyrosine kinase Syk in retinoic acid-induced leukemic HL-60 cell differentiation
Imbrasaitė, A., & Kalvelytė, A. V. (2010) · Biologija · doi:10.2478/v10054-010-0009-0
Investigating the Function of Hemogen during Erythroid Differentiation
Zhang, C. X. Y. (2010) · uO Research (University of Ottawa) · doi:10.20381/ruor-13735
[Reviews] Pathogenetic and clinical significance of genetic abnormalities in acute myeloid leukemia
Matsumura, I. (2010) · Institutional Repositories DataBase (IRDB)
Leukemia Stem Cells, A Pioneering Paradigmatic Model
Pearce, D. J., & Bonnet, D. A. (2007) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789812775870_0009
Regulation of the potential tumorsuppressor gene mad1 by G-CSF
Jiang, K., & Lüscher, B. (2006) · RWTH Publications (RWTH Aachen)
MOLECULAR GENETICS OF PEDIATRIC AML IN EGYPT AND ITS IMPACT ON SURVIVAL
Elnahas, Y., Elattar, I. A., & Zekri, W. (2006) · Research in Oncology · doi:10.21608/resoncol.2016.366
Cancer Modeling: From Optimal Cell Renewal to Immunotherapy
Alvarado, C. L. (2017) · UNM’s Digital Repository (University of New Mexico)
Robetorye, R. S. (2017) · Molecular pathology library · doi:10.1007/978-3-319-62146-3_2
The Role of PU.1 in Lipid Metabolism and Cell Cycle Regulation in Myeloid Progenitor Cells
Rhee, J. (2018) · Scholarship@Western (Western University)
Leo Sachs. 14 October 1924—12 December 2013
Groner, Y., Sachs, P., & Lotem, J. (2019) · Biographical Memoirs of Fellows of the Royal Society · doi:10.1098/rsbm.2018.0027
The Role of JAK2 in Myeloproliferative Neoplasms
Lally, J. (2017) · Lincoln Repository (University of Lincoln) · doi:10.24385/lincoln.24326068
Cytotoxic Effects of All-Trans-Retinoic Acid with Cisplatin on Esophageal Cancer Cell Line (KYSE30)
Abbasi, A., Amani, M., Najafzadeh, N., & Mazani, M. (2014) · مجله دانشگاه علوم پزشکی اراک
Kanlı, A., Gülkaç, M. D., & Savlı, H. (2020) · Kocaeli Medical Journal · doi:10.5505/ktd.2020.27879
O efeito de plantas nativas sobre o câncer cervical
Padilha, G., Porta, V. G. L., Núñez, J. G., Pinheiro, J. D. S., Silveira, G. F., Garcia, H. O., Pfaffenseller, B., Apel, M. A., & Bruno, A. N. (2020) · ScientiaTec · doi:10.35819/scientiatec.v7i03.2394
Using Proteomics To Elucidate Critical Signaling Pathways
Ahmed, H. M. J. (2012) · King Abdullah University of Science and Technology Repository (King Abdullah University of Science and Technology) · doi:10.25781/kaust-5t4i7
Gene Repression and Cell Cycle Regulation by PU.1 in Acute Myeloid Leukemia
Ziliotto, R. G. (2013) · Scholarship@Western (Western University)
Faculty Opinions recommendation of DNMT1-interacting RNAs block gene-specific DNA methylation.
Taniuchi, I. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.718137975.793485609
Risikoadaptierte Therapie der akuten myeloischen Leukämie
Hiddemann, W., Spiekermann, K., Braess, J., Feuring‐Buske, M., Buske, C., & Büchner, T. (2006) · Der Internist · doi:10.1007/s00108-006-1622-y
Schulz, W. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-16286-2_10
Lidonnici, M. R., Audia, A., Soliera, A. R., di Prisco, M., Ferrari‐Amorotti, G., Waldron, T. J., Donato, N. J., Zhang, Y., Martinez, R. V. P., Holyoake, T. L., et al. (2023) · doi:10.1158/0008-5472.c.6500832
Departamento de Matemática Pura, U. N. M. D. S. M., & Medina-Diaz, J. (2023) · Selecciones Matemáticas · doi:10.17268/sel.mat.2023.02.03
Schulz, W. A. (2024) · Springer eBooks · doi:10.1007/978-3-031-42806-7_10
Waliullah, A. S. M., Qiu, K., Dziegielewska, B., Tran, M. L., Nguyen, N. N., Wang, L., Pan, A., Segovia, N., Ummarino, S., Zhang, J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.19.638695
Self-citationZhang, L., Zhong, J., Luo, Y., Ye, Q., Jin, Y., Liu, C., Lai, P., Li, H., Pan, J., & Jin, B. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110320
“Given that MLL-AF9 AML is characterized by blocked differentiation (32, 33), we examined the effect of SMYD3 on the differentiation of AML cells.”
Fisher Information and the Dynamics of Multicellular Ageing
Hale, Z. F., Cánez, G. A., & Michaels, T. C. T. (2025) · Entropy · doi:10.3390/e27060638
Triad1 and its role during myelopoiesis.
Marteijn, J. A. F. (2007) · Radboud Repository (Radboud University)
Mechanisms of action of ELF5 in breast cancer
Piggin, C. (2018) · UNSWorks (University of New South Wales, Sydney, Australia) · doi:10.26190/unsworks/3362
Additional file 1 of Transcriptionally imprinted glycomic signatures of acute myeloid leukemia
Blöchl, C., Wang, D., Mayboroda, O. A., Lageveen‐Kammeijer, G. S. M., & Wuhrer, M. (2024) · Figshare · doi:10.6084/m9.figshare.26568559
Metadata
- Authors
- Tenen, D. G.
- Affiliations
- Harvard University (US)
- Corresponding author
- Tenen, Daniel G.
- ORCID
- Tenen, Daniel G.
- Venue
- Nature Reviews Cancer
- Published
- 2003-02
- Volume
- 3
- Issue
- 2
- Pages
- 89-101
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2050249118
- Cited by
- 612
- References
- 128
- Citations by year
- 2026: 7 · 2025: 20 · 2024: 16 · 2023: 15 · 2022: 6 · 2021: 23 · 2020: 20 · 2019: 16 · 2018: 17 · 2017: 22 · 2016: 20 · 2015: 18 · 2014: 25 · 2013: 33 · 2012: 27
- FWCI
- 7.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- acute myeloid leukemia, cell differentiation, transcription factors, lineage-specific transcription factors, hematopoietic differentiation, transcription factor mutations, solid tumors
- MeSH terms
- Cell Differentiation, Humans, Mutation, Neoplasms, Transcription Factors, Leukemia, Myeloid, Acute
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.